NIH PAR · NCI · R01
PAR-25-144: Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (hereafter referred to as evidence-based interventions).Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective,…
- NOFO number
- PAR-25-144
- Type
- PAR
- Activity code
- R01
- Primary institute
- NCI · National Cancer Institute
- Clinical trials
- Optional
- Posted
- Oct 29, 2024
- Opens
- Jan 5, 2025
- Expires
- Jan 8, 2028
PAR-25-144 due dates
3 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Application Due Date(s) | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| February 05, 2025 | March 05, 2025 * | May 07, 2025 * | July 2025 | October 2025 | December 2025 |
| June 05, 2025 | July 05, 2025 * | September 07, 2025 * | November 2025 | January 2026 | April 2026 |
| October 05, 2025 | November 05, 2025 * | January 07, 2026 * | March 2026 | May 2026 | July 2026 |
| February 05, 2026 | March 05, 2026 * | May 07, 2026 * | July 2026 | October 2026 | December 2026 |
| June 05, 2026 | July 05, 2026 * | Not Applicable | November 2026 | January 2027 | April 2027 |
| October 05, 2026 | November 05, 2026 * | Not Applicable | March 2027 | May 2027 | July 2027 |
| February 05, 2027 | March 05, 2027 * | Not Applicable | July 2027 | October 2027 | December 2027 |
| June 05, 2027 | July 05, 2027 * | Not Applicable | November 2027 | January 2028 | April 2028 |
| October 05, 2027 | November 05, 2027 * | Not Applicable | March 2028 | May 2028 | July 2028 |
Projects funded under PAR-25-144
NIH RePORTER lists 53 projects funded under PAR-25-144 in FY2022–FY2026, with $45.3M in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.
Projects funded
53
Distinct projects, FY2022–FY2026
New awards
49
Type 1 (new project) award records
NIH funding
$45.3M
Award dollars under PAR-25-144, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 58 | 49 | $45.3M |
Institutions with the most funding
- University of Michigan at Ann Arbor$3.5M · 5 projects
- University of California, San Francisco$3.0M · 2 projects
- Cleveland Clinic Lerner Com-Cwru$2.4M · 1 project
- Northwestern University$1.7M · 2 projects
- Johns Hopkins University$1.6M · 2 projects
- University of Alabama at Birmingham$1.5M · 2 projects
- University of Nebraska Medical Center$1.5M · 2 projects
- Dartmouth College$1.5M · 1 project
Funding institutes
- NHLBI$25.9M · 31
- NCI$5.2M · 10
- NIDDK$3.9M · 4
- NIMHD$2.5M · 3
- NINR$2.4M · 3
- NICHD$2.2M · 3
- NIAID$1.7M · 2
- NIA$796K · 1
Activity codes funded
- R0157 records
- R561 record
Most recent new awards
- Defining Successful Care Planning Processes and Outcomes Informed by Patient and Caregiver Perspectives (opens NIH RePORTER)
Kaiser Foundation Research Institute · 1R01NR022266-01 · NINR · Notice Sep 18, 2026
$884KR01
- Cutting Out Stigma: A Barbershop-Based Cluster-Randomized Trial to Improve HIV Testing, PrEP Uptake, and Stigma Reduction (opens NIH RePORTER)
Massachusetts General Hospital · 1R01MD021855-01 · NIMHD · Notice Sep 17, 2026
$833KR01
- BrighT STAR SIRIUS: a hybrid trial evaluating the impact of a comprehensive diagnostic stewardship toolkit on blood culture overuse in critically ill children (opens NIH RePORTER)
Children's Hosp of Philadelphia · 1R01HL183352-01A1 · NHLBI · Notice Sep 17, 2026
$1.1MR01
- An Adaptive Implementation Intervention for Induction of Labor (opens NIH RePORTER)
University of Michigan at Ann Arbor · 1R01HD120488-01A1 · NICHD · Notice Sep 17, 2026
$683KR01
- Tailored strategies to improve recommended postpartum care and maternal health outcomes (opens NIH RePORTER)
Thomas Jefferson University · 1R01HD122769-01 · NICHD · Notice Sep 17, 2026
$850KR01
- Evaluating Strategies to Minimize Unnecessary Interventions in Older Women with Breast Cancer (opens NIH RePORTER)
University of Michigan at Ann Arbor · 1R01CA315493-01 · NCI · Notice Sep 17, 2026
$536KR01
What its predecessor PAR-22-105 funded
PAR-25-144 reissues PAR-22-105. Its funding history is the best guide to who wins under this program: 82 projects and $155.7M in FY2022–FY2026.
Projects funded
82
Distinct projects, FY2022–FY2026
New awards
78
Type 1 (new project) award records
NIH funding
$155.7M
Award dollars under PAR-22-105, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 21 | 21 | $15.5M |
| FY2024 | 49 | 30 | $33.2M |
| FY2025 | 105 | 24 | $51.3M |
| FY2026 | 108 | 3 | $55.6M |
Institutions with the most funding
- New York University School of Medicine$14.3M · 6 projects
- University of Pennsylvania$9.2M · 4 projects
- Yale University$7.0M · 3 projects
- University of Washington$6.7M · 4 projects
- Boston College$4.5M · 2 projects
- Columbia University Health Sciences$3.9M · 2 projects
- Dana-Farber Cancer Inst$3.6M · 1 project
- Rand Corporation$3.5M · 2 projects
Most recent new awards
- Decentralization and Scale-Up of Integrated Chronic Care Clinics in Malawi: A Stepped-Wedge Cluster Randomized Trial (opens NIH RePORTER)
Rand Corporation · 1R01MH139372-01A1 · NIMH · Notice Aug 18, 2026
$677KR01
- Mental Wellness Coordinated Specialty Care (mWell-CSC) in Mozambique: Implementing evidence-based early intervention services for young people with untreated psychosis (opens NIH RePORTER)
New York State Psychiatric Institute DBA Research Foundation for Mental Hygiene, Inc · 1R01MH138802-01 · NIMH · Notice Aug 13, 2026
$531KR01
- Comparative evaluation of strategies to scale-up an evidenced based social network and HIV self-testing and linkage to prevention and care intervention for highly mobile men (opens NIH RePORTER)
University of California, San Francisco · 1R01MH142064-01 · NIMH · Notice Jul 13, 2026
$712KR01
- A Type 2 Hybrid Effectiveness-Implementation Study of Time Limited Trials to Reduce Potentially Non-Beneficial Treatments for Critically Ill Patients with Advanced Medical Illnesses (opens NIH RePORTER)
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center · 1R01AG095167-01 · NIA · Notice Sep 24, 2025
$633KR01
- Evaluating implementation of the HEARTS hypertension and diabetes primary care model in Guatemala (opens NIH RePORTER)
University of Michigan at Ann Arbor · 1R01HL178752-01 · NHLBI · Notice Sep 22, 2025
$335KR01
- Community-based Implementation of Hypertension Screening and Telehealth Systems in Kenya (COMPASS) (opens NIH RePORTER)
University of California, San Francisco · 1R01HL180265-01 · NHLBI · Notice Sep 19, 2025
$437KR01
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
22 NIH institutes and offices take applications under PAR-25-144. Contact the program officer at the institute that fits your research before applying.
- NCI · National Cancer Institute
- NEI · National Eye Institute
- NHLBI · National Heart, Lung, and Blood Institute
- NHGRI · National Human Genome Research Institute
- NIA · National Institute on Aging
- NIAAA · National Institute on Alcohol Abuse and Alcoholism
- NIAID · National Institute of Allergy and Infectious Diseases
- NIAMS · National Institute of Arthritis and Musculoskeletal and Skin Diseases
- NICHD · Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NIDCD · National Institute on Deafness and Other Communication Disorders
- NIDCR · National Institute of Dental and Craniofacial Research
- NIDDK · National Institute of Diabetes and Digestive and Kidney Diseases
- NIDA · National Institute on Drug Abuse
- NIEHS · National Institute of Environmental Health Sciences
- NIMH · National Institute of Mental Health
- NINDS · National Institute of Neurological Disorders and Stroke
- NINR · National Institute of Nursing Research
- NIMHD · National Institute on Minority Health and Health Disparities
- NCCIH · National Center for Complementary and Integrative Health
- THRO
- ODP
- OBSSR
Related notices
Jan 28, 2026 · NOT-OD-26-029
NIH Removing AIDS Application Due Dates from NOFOs. See Notice NOT-OD-26-029.
Mar 31, 2025
This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.
Dec 20, 2024 · NOT-CA-25-001
Notice of Correction to the Dissemination and Implementation Research in Health" Notices of Funding Opportunity PAR-25-143 and PAR-25-144. See Notice NOT-CA-25-001.April 4, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25, 2025.
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Notices of Special Interest (NOSIs)
NIH has attached 30 NOSIs to PAR-25-144; none are active now. A NOSI flags a topic an institute wants to fund through this NOFO.
Award terms
- Application types allowed
- NewRenewalResubmissionRevision The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Application budgets are not limited but need to reflect the actual needs of the proposed project.
- Project period
- The maximum project period is 5 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-22-105.
- Companion NOFOs: PAR-25-233.
Other open NOFOs for R01
- PAR-25-336Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)NCI · next due Nov 16, 2026
- PAR-27-072Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)NCI · next due Feb 5, 2027
- PAR-25-337Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)NCI · next due Feb 5, 2027
- PAR-25-338Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)NCI · next due Feb 5, 2027
- PAR-25-243Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)NCI · next due Feb 5, 2027
- PA-25-172Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)NCI · next due Feb 5, 2027
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.